Jiabing Wang, Lili Huang, Chanchan Chen, Ge Li, Jingwen Xie, Mengya Shen, Qian Chen, Wulan Li, Wenfei He, Peihong Qiu, Jianzhang Wu. Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ Acta Pharmaceutica Sinica B 9 (2019) 335–350J. Acta Pharmaceutica Sinica B, 2022, 12(8): 3451-3452. DOI: 10.1016/j.apsb.2022.05.030
|
Citation:
|
Jiabing Wang, Lili Huang, Chanchan Chen, Ge Li, Jingwen Xie, Mengya Shen, Qian Chen, Wulan Li, Wenfei He, Peihong Qiu, Jianzhang Wu. Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ Acta Pharmaceutica Sinica B 9 (2019) 335–350J. Acta Pharmaceutica Sinica B, 2022, 12(8): 3451-3452. DOI: 10.1016/j.apsb.2022.05.030
|
Jiabing Wang, Lili Huang, Chanchan Chen, Ge Li, Jingwen Xie, Mengya Shen, Qian Chen, Wulan Li, Wenfei He, Peihong Qiu, Jianzhang Wu. Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ Acta Pharmaceutica Sinica B 9 (2019) 335–350J. Acta Pharmaceutica Sinica B, 2022, 12(8): 3451-3452. DOI: 10.1016/j.apsb.2022.05.030
|
Citation:
|
Jiabing Wang, Lili Huang, Chanchan Chen, Ge Li, Jingwen Xie, Mengya Shen, Qian Chen, Wulan Li, Wenfei He, Peihong Qiu, Jianzhang Wu. Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ Acta Pharmaceutica Sinica B 9 (2019) 335–350J. Acta Pharmaceutica Sinica B, 2022, 12(8): 3451-3452. DOI: 10.1016/j.apsb.2022.05.030
|